Accelr8 Technology Corp (NYSEMKT:AXK)

CAPS Rating: No stars

The Company intends to customize its technologies to the specific requirements of large licensees as well as develop new rapid pathogen detection assays.

Recs

2
Player Avatar FAOFool (80.93) Submitted: 8/30/2011 11:51:33 PM : Outperform Start Price: $3.17 AXK Score: -37.30

Solid financials support long-term technology development.

Featured Broker Partners


Advertisement